Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States

Traditional influenza vaccines may be less immunogenic in adults ≥65 years of age due to immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose influenza vaccine (HD-IIV3)—were developed to overcome this problem. We summarize estimates...

Full description

Bibliographic Details
Main Authors: Constantina Boikos, Ian McGovern, Justin R. Ortiz, Joan Puig-Barberà, Eve Versage, Mendel Haag
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
influenza
influenza vaccines
relative vaccine effectiveness
immunosenescence
Online Access:https://www.mdpi.com/2076-393X/10/9/1456

Similar Items

Similar Items